Comparison of high-density lipoprotein cholesterol to apolipoprotein A-I and A-II to predict coronary calcium and the effect of insulin resistance

American Journal of Cardiology

Volumn 107, Issue 3, 2011, Pages 393-398

  Martin, Seth S ^a,c   Qasim, Atif N ^a   Wolfe, Megan ^a   St Clair, Caitlin ^a   Schwartz, Stanley ^b   Iqbal, Nayyar ^b   Schutta, Mark ^b   Bagheri, Roshanak ^d   Mehta, Nehal N ^a   Rader, Daniel J ^a,b   Reilly, Muredach P ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTOR VARIABLE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADULT; APOLIPOPROTEIN A-I; CALCINOSIS; CHOLESTEROL, HDL; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOPROTEIN(A); MALE; MIDDLE AGED;

EID: 78951495528     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.09.033     Document Type: Article

References (30)

1. E.M. deGoma, R.L. deGoma, and D.J. Rader Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches J Am Coll Cardiol 51 2008 2199 2211
2. K. El Harchaoui, B.J. Arsenault, R. Franssen, J.P. Despres, G.K. Hovingh, E.S. Stroes, J.D. Otvos, N.J. Wareham, J.J. Kastelein, K.T. Khaw, and S.M. Boekholdt High-density lipoprotein particle size and concentration and coronary risk Ann Intern Med 150 2009 84 93
3. S.S. Martin, A.N. Qasim, N.N. Mehta, M. Wolfe, K. Terembula, S. Schwartz, N. Iqbal, M. Schutta, R. Bagheri, and M.P. Reilly Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites Diabetes 58 2009 1887 1892
4. M.P. Reilly, M.L. Wolfe, A.R. Localio, and D.J. Rader Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach Atherosclerosis 173 2004 69 78
5. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
6. J. Genest, R. McPherson, J. Frohlich, T. Anderson, N. Campbell, A. Carpentier, P. Couture, R. Dufour, G. Fodor, G.A. Francis, S. Grover, M. Gupta, R.A. Hegele, D.C. Lau, L. Leiter, G.F. Lewis, E. Lonn, G.B. Mancini, D. Ng, G.J. Pearson, A. Sniderman, J.A. Stone, and E. Ur 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult2009 recommendations Can J Cardiol 25 2009 567 579
7. R.L. McClelland, H. Chung, R. Detrano, W. Post, and R.A. Kronmal Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA) Circulation 113 2006 30 37
8. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber High density lipoprotein as a protective factor against coronary heart disease The Framingham Study Am J Med 62 1977 707 714
9. G.J. Miller, and N.E. Miller Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease Lancet 1 1975 16 19
10. P.J. Barter, and K.A. Rye High density lipoproteins and coronary heart disease Atherosclerosis 121 1996 1 12
11. H. Li, R.L. Reddick, and N. Maeda Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice Arterioscler Thromb 13 1993 1814 1821
12. R. Frikke-Schmidt Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population Atherosclerosis 208 2010 305 316
13. P.J. Barter, M. Caulfield, M. Eriksson, S.M. Grundy, J.J. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J.C. Tardif, D.D. Waters, C.L. Shear, J.H. Revkin, K.A. Buhr, M.R. Fisher, A.R. Tall, and B. Brewer Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122
14. S.A. Grover, M. Kaouache, L. Joseph, P. Barter, and J. Davignon Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels Arch Intern Med 169 2009 1775 1780
15. M. Briel, I. Ferreira-Gonzalez, J.J. You, P.J. Karanicolas, E.A. Akl, P. Wu, B. Blechacz, D. Bassler, X. Wei, A. Sharman, I. Whitt, S. Alves da Silva, Z. Khalid, A.J. Nordmann, Q. Zhou, S.D. Walter, N. Vale, N. Bhatnagar, C. O'Regan, E.J. Mills, H.C. Bucher, V.M. Montori, and G.H. Guyatt Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis BMJ 338 2009 b92
16. J.C. Fruchart, F. Sacks, M.P. Hermans, G. Assmann, W.V. Brown, R. Ceska, M.J. Chapman, P.M. Dodson, P. Fioretto, H.N. Ginsberg, T. Kadowaki, J.M. Lablanche, N. Marx, J. Plutzky, Z. Reiner, R.S. Rosenson, B. Staels, J.K. Stock, R. Sy, C. Wanner, A. Zambon, and P. Zimmet The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia Am J Cardiol 102 suppl 2008 1K 34K
17. J.J. Albers, and F. Aladjem Precipitation of 125 I-labeled lipoproteins with specific polypeptide antisera Evidence for two populations with differing polypeptide compositions in human high density lipoproteins Biochemistry 10 1971 3436 3442
18. R.S. Birjmohun, G.M. Dallinga-Thie, J.A. Kuivenhoven, E.S. Stroes, J.D. Otvos, N.J. Wareham, R. Luben, J.J. Kastelein, K.T. Khaw, and S.M. Boekholdt Apolipoprotein A-II is inversely associated with risk of future coronary artery disease Circulation 116 2007 2029 2035
19. R.S. Elkeles, M.D. Feher, M.D. Flather, I.F. Godsland, F. Nugara, W. Richmond, M.B. Rubens, and D. Wang The association of coronary calcium score and conventional cardiovascular risk factors in type 2 diabetic subjects asymptomatic for coronary heart disease (the PREDICT study) Diabet Med 21 2004 1129 1134
20. L.E. Wagenknecht, D.W. Bowden, J.J. Carr, C.D. Langefeld, B.I. Freedman, and S.S. Rich Familial aggregation of coronary artery calcium in families with type 2 diabetes Diabetes 50 2001 861 866
21. Y. Arad, D. Newstein, F. Cadet, M. Roth, and A.D. Guerci Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study Arterioscler Thromb Vasc Biol 21 2001 2051 2058
22. H.S. Hecht, H.R. Superko, L.K. Smith, and B.P. McColgan Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment Am J Cardiol 87 2001 406 412
23. D.J. Rader, J.M. Hoeg, and H.B. Brewer Jr Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease Ann Intern Med 120 1994 1012 1025
24. J.E. Buring, G.T. O'Connor, S.Z. Goldhaber, B. Rosner, P.N. Herbert, C.B. Blum, J.L. Breslow, and C.H. Hennekens Decreased HDL2 and HDL3 cholesterol, apo A-I and apo A-II, and increased risk of myocardial infarction Circulation 85 1992 22 29
25. M. Syvanne, J. Kahri, K.S. Virtanen, and M.R. Taskinen HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus Circulation 92 1995 364 370
26. P. Alaupovic, W.J. Mack, C. Knight-Gibson, and H.N. Hodis The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial Arterioscler Thromb Vasc Biol 17 1997 715 722
27. G. Bruno, F. Merletti, A. Biggeri, G. Bargero, S. Prina-Cerai, G. Pagano, and P. Cavallo-Perin Effect of age on the association of non-high-density- lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study Diabetologia 49 2006 937 944
28. A.R. Sharrett, C.M. Ballantyne, S.A. Coady, G. Heiss, P.D. Sorlie, D. Catellier, and W. Patsch Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study Circulation 104 2001 1108 1113
29. G. Luc, J.M. Bard, J. Ferrieres, A. Evans, P. Amouyel, D. Arveiler, J.C. Fruchart, and P. Ducimetiere Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME study Arterioscler Thromb Vasc Biol 22 2002 1155 1161
30. P.M. Sweetnam, C.H. Bolton, L.G. Downs, P.N. Durrington, M.I. MacKness, P.C. Elwood, and J.W. Yarnell Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study Eur J Clin Invest 30 2000 947 956